2-Propylimidazole → HCID 19438758, compound

HRID 1733888Notes

Reaction equation

F[C:2]1[CH:11]=[C:10]2[C:5]([NH:6][C:7](=[O:16])[C:8]3[N:9]2[C:12](=[O:15])[NH:13][N:14]=3)=[CH:4][C:3]=1[N+:17]([O-:19])=[O:18].[CH2:20]([C:23]1[NH:24][CH:25]=[CH:26][N:27]=1)[CH2:21][CH3:22]>>[CH2:20]([C:23]1[N:24]([C:2]2[CH:11]=[C:10]3[C:5]([NH:6][C:7](=[O:16])[C:8]4[N:9]3[C:12](=[O:15])[NH:13][N:14]=4)=[CH:4][C:3]=2[N+:17]([O-:19])=[O:18])[CH:25]=[CH:26][N:27]=1)[CH2:21][CH3:22]

Participants

Reactant 2

HCID 1626172-Propylimidazole

HCID 19438785HCID 19438785, compound

Product 1

HCID 19438758HCID 19438758, compound

Procedure

The title compound was prepared from 8-fluoro-7-nitro[1,2,4]triazolo[4,3-a]quinoxaline-1,4(2H,5H)-dione and 2-n-propylimidazole by a method analogous to the method described in example 11. M.p. 260° C. decomp.

Sources & evidence

ORD record: ord-36b7b255f765422ba40fbc375de2d203
Source dataset: uspto-grants-1996_07
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US05532236

Reaction notes

Loading…